Yield10 Bioscience, Inc. announced that it has entered into a non-binding Letter of Intent with new investor Marathon Petroleum Corporation for a private placement of senior unsecured convertible promissory note for gross proceeds of $1 million on May 1, 2023. The notes are convertible into common shares of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
199.5 USD | +0.19% | +2.30% | +34.48% |
Apr. 25 | Goldman Sachs Adjusts Price Target on Marathon Petroleum to $213 From $211 | MT |
Apr. 24 | Suncor Energy Raises Doubt Over Commencement of Trans Mountain Expansion Project Starting May | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.48% | 71.89B | |
+12.39% | 223B | |
+13.06% | 108B | |
+17.36% | 103B | |
+18.10% | 66.79B | |
+28.56% | 55.06B | |
+32.11% | 28.14B | |
-10.78% | 21.04B | |
+9.89% | 19.56B | |
-28.84% | 18.51B |
- Stock Market
- Equities
- MPC Stock
- News Marathon Petroleum Corporation
- Yield10 Bioscience, Inc. announced that it expects to receive $1 million in funding from Marathon Petroleum Corporation